Basic fibroblast growth factor is essential to maintain endothelial progenitor cell phenotype in TR-BME2 cells

Yoshimichi Sai, Tomohiro Nishimura, Mariko Muta, Hisashi Iizasa, Takashi Miyata, Emi Nakashima

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Endothelial progenitor cells (EPC) can differentiate into both endothelial cells and contractile smooth muscle cells (SMC). Previously we reported that TR-BME2 cells, a model for EPC, developed contractile SMC-like characteristics in culture medium deprived of endothelial cell growth factors (ECGF). The aim of the present study was to clarify the effect of one of these factors, basic fibroblast growth factor (bFGF) on differentiation of EPC. First it was confirmed that bFGF receptor (FGFR-1) mRNA is expressed in TRBME2 cultured in both ECGF-rich and ECGF-deprived medium. When TR-BME2 cells were cultured in ECGF-deprived medium, they differentiated into contractile SMC. Expression of an undifferentiated state marker, CD133, and proliferation of TR-BME2 were both reduced by ECGF deprivation, but these changes were diminished in the presence of bFGF. mRNA expression of smooth muscle α-actin (SMA) and smooth muscle protein 22 (SM22), which are contractile SMC markers, was induced by deprivation of ECGF and the induction was suppressed by bFGF. In vascular endothelial cell growth factor (VEGF)-induced tube formation assay, TR-BME2 cells formed tube structures in the presence of bFGF, but not in its absence. Our results indicate that bFGF is essential for the maintenance of EPC phenotype, serving to suppress differentiation to contractile SMC.

Original languageEnglish
Pages (from-to)688-693
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume37
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Endothelial Growth Factors
Fibroblast Growth Factor 2
Endothelial Cells
Phenotype
Smooth Muscle Myocytes
Smooth Muscle
Receptor, Fibroblast Growth Factor, Type 1
Messenger RNA
Muscle Proteins
Endothelial Progenitor Cells
Vascular Endothelial Growth Factor A
Culture Media
Actins
Cultured Cells
Maintenance

Keywords

  • Differentiation
  • Endothelial progenitor cell
  • Proliferation
  • Tube formation
  • Vascular smooth muscle cell
  • Vasculogenesis

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology
  • Medicine(all)

Cite this

Basic fibroblast growth factor is essential to maintain endothelial progenitor cell phenotype in TR-BME2 cells. / Sai, Yoshimichi; Nishimura, Tomohiro; Muta, Mariko; Iizasa, Hisashi; Miyata, Takashi; Nakashima, Emi.

In: Biological and Pharmaceutical Bulletin, Vol. 37, No. 4, 2014, p. 688-693.

Research output: Contribution to journalArticle

Sai, Yoshimichi ; Nishimura, Tomohiro ; Muta, Mariko ; Iizasa, Hisashi ; Miyata, Takashi ; Nakashima, Emi. / Basic fibroblast growth factor is essential to maintain endothelial progenitor cell phenotype in TR-BME2 cells. In: Biological and Pharmaceutical Bulletin. 2014 ; Vol. 37, No. 4. pp. 688-693.
@article{a0c7eadf3d724a459249c7a89548694a,
title = "Basic fibroblast growth factor is essential to maintain endothelial progenitor cell phenotype in TR-BME2 cells",
abstract = "Endothelial progenitor cells (EPC) can differentiate into both endothelial cells and contractile smooth muscle cells (SMC). Previously we reported that TR-BME2 cells, a model for EPC, developed contractile SMC-like characteristics in culture medium deprived of endothelial cell growth factors (ECGF). The aim of the present study was to clarify the effect of one of these factors, basic fibroblast growth factor (bFGF) on differentiation of EPC. First it was confirmed that bFGF receptor (FGFR-1) mRNA is expressed in TRBME2 cultured in both ECGF-rich and ECGF-deprived medium. When TR-BME2 cells were cultured in ECGF-deprived medium, they differentiated into contractile SMC. Expression of an undifferentiated state marker, CD133, and proliferation of TR-BME2 were both reduced by ECGF deprivation, but these changes were diminished in the presence of bFGF. mRNA expression of smooth muscle α-actin (SMA) and smooth muscle protein 22 (SM22), which are contractile SMC markers, was induced by deprivation of ECGF and the induction was suppressed by bFGF. In vascular endothelial cell growth factor (VEGF)-induced tube formation assay, TR-BME2 cells formed tube structures in the presence of bFGF, but not in its absence. Our results indicate that bFGF is essential for the maintenance of EPC phenotype, serving to suppress differentiation to contractile SMC.",
keywords = "Differentiation, Endothelial progenitor cell, Proliferation, Tube formation, Vascular smooth muscle cell, Vasculogenesis",
author = "Yoshimichi Sai and Tomohiro Nishimura and Mariko Muta and Hisashi Iizasa and Takashi Miyata and Emi Nakashima",
year = "2014",
doi = "10.1248/bpb.b13-00841",
language = "English",
volume = "37",
pages = "688--693",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "4",

}

TY - JOUR

T1 - Basic fibroblast growth factor is essential to maintain endothelial progenitor cell phenotype in TR-BME2 cells

AU - Sai, Yoshimichi

AU - Nishimura, Tomohiro

AU - Muta, Mariko

AU - Iizasa, Hisashi

AU - Miyata, Takashi

AU - Nakashima, Emi

PY - 2014

Y1 - 2014

N2 - Endothelial progenitor cells (EPC) can differentiate into both endothelial cells and contractile smooth muscle cells (SMC). Previously we reported that TR-BME2 cells, a model for EPC, developed contractile SMC-like characteristics in culture medium deprived of endothelial cell growth factors (ECGF). The aim of the present study was to clarify the effect of one of these factors, basic fibroblast growth factor (bFGF) on differentiation of EPC. First it was confirmed that bFGF receptor (FGFR-1) mRNA is expressed in TRBME2 cultured in both ECGF-rich and ECGF-deprived medium. When TR-BME2 cells were cultured in ECGF-deprived medium, they differentiated into contractile SMC. Expression of an undifferentiated state marker, CD133, and proliferation of TR-BME2 were both reduced by ECGF deprivation, but these changes were diminished in the presence of bFGF. mRNA expression of smooth muscle α-actin (SMA) and smooth muscle protein 22 (SM22), which are contractile SMC markers, was induced by deprivation of ECGF and the induction was suppressed by bFGF. In vascular endothelial cell growth factor (VEGF)-induced tube formation assay, TR-BME2 cells formed tube structures in the presence of bFGF, but not in its absence. Our results indicate that bFGF is essential for the maintenance of EPC phenotype, serving to suppress differentiation to contractile SMC.

AB - Endothelial progenitor cells (EPC) can differentiate into both endothelial cells and contractile smooth muscle cells (SMC). Previously we reported that TR-BME2 cells, a model for EPC, developed contractile SMC-like characteristics in culture medium deprived of endothelial cell growth factors (ECGF). The aim of the present study was to clarify the effect of one of these factors, basic fibroblast growth factor (bFGF) on differentiation of EPC. First it was confirmed that bFGF receptor (FGFR-1) mRNA is expressed in TRBME2 cultured in both ECGF-rich and ECGF-deprived medium. When TR-BME2 cells were cultured in ECGF-deprived medium, they differentiated into contractile SMC. Expression of an undifferentiated state marker, CD133, and proliferation of TR-BME2 were both reduced by ECGF deprivation, but these changes were diminished in the presence of bFGF. mRNA expression of smooth muscle α-actin (SMA) and smooth muscle protein 22 (SM22), which are contractile SMC markers, was induced by deprivation of ECGF and the induction was suppressed by bFGF. In vascular endothelial cell growth factor (VEGF)-induced tube formation assay, TR-BME2 cells formed tube structures in the presence of bFGF, but not in its absence. Our results indicate that bFGF is essential for the maintenance of EPC phenotype, serving to suppress differentiation to contractile SMC.

KW - Differentiation

KW - Endothelial progenitor cell

KW - Proliferation

KW - Tube formation

KW - Vascular smooth muscle cell

KW - Vasculogenesis

UR - http://www.scopus.com/inward/record.url?scp=84898743126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898743126&partnerID=8YFLogxK

U2 - 10.1248/bpb.b13-00841

DO - 10.1248/bpb.b13-00841

M3 - Article

C2 - 24694617

AN - SCOPUS:84898743126

VL - 37

SP - 688

EP - 693

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 4

ER -